Biotinylated Mouse 4-1BB / TNFRSF9 (24-211) Protein, Avitag™,His Tag (MALS verified)

사용자 리뷰
제품 번호/규격
가격
수량
41B-M82E8-25ug
$360.00
41B-M82E8-200ug
$1565.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonyms

    TNFRSF9, 4-1BB, CD137, CDw137, ILA

  • Source

    Biotinylated Mouse 4-1BB (24-211), Avitag,His Tag (41B-M82E8) is expressed from human 293 cells (HEK293). It contains AA Val 24 - Leu 211 (Accession # Q8R037-1).

    Predicted N-terminus: Val 24

    Request for sequence
  • Molecular Characterization

    4-1BB Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag.

    The protein has a calculated MW of 24.5 kDa. The protein migrates as 30-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    4-1BB SDS-PAGE

    Biotinylated Mouse 4-1BB (24-211), Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    4-1BB SEC-MALS

    The purity of Biotinylated Mouse 4-1BB (24-211), Avitag,His Tag (Cat. No. 41B-M82E8) is more than 85% and the molecular weight of this protein is around 35-50 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     4-1BB ELISA

    Immobilized Biotinylated Mouse 4-1BB / TNFRSF9 (24-211), Avitag,His Tag (Cat. No. 41B-M82E8) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Mouse 4-1BB Ligand, Fc Tag (Cat. No. 41L-M5257) with a linear range of 0.3-2 ng/mL (QC tested).

    Protocol
  •  4-1BB ELISA

    Immobilized Mouse 4-1BB Ligand, Fc Tag (Cat. No. 41L-M5257) at 5 μg/mL (100 μL/well) can bind Biotinylated Mouse 4-1BB / TNFRSF9 (24-211), Avitag,His Tag (Cat. No. 41B-M82E8) with a linear range of 0.3-20 ng/mL (Routinely tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Tumor necrosis factor receptor superfamily member 9

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    77 상세

  • 최고 개발 단계:

    Phase 3 Clinical

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호